HMGB1 and serum lipopolysaccharide activity: The inhibitory effects ofmetformin on inflammation in lipopolysaccharide-treatedcells and endotoxemia in mice were shown to be inducedby inhibiting the release of HMGB1 a prominent proinflammatorycytokine and damage associated molecularpattern (DAMP) (33).